Bill number does not exist. Enter a vaild keyword.

Committee Testimony and Witness Signup

SB0323 - Public Health - Medications to Treat an Opioid Use Disorder - Preferred and Nonpreferred Medications

Finance 2/8/2022 1:00:00 PM
Health and Government Operations 3/30/2022 1:30:00 PM
As of: 9/27/2022 7:19:59 AM
Name Organization Position Testimony Committee
Senator Augustine, Senator Augustine FAV Oral Testimony FIN
Tompsett, Thomas Harris Jones & Malone FWA SB 323 - SWA - MPS WPS.pdf FIN
Rizkallah, Haley Maryland Coalition of Families FAV MCF_Fav_SB 323.pdf FIN
Rabbitt, Dan Behavioral Health System Baltimore FAV SB 323_Medicaid Prohibition on MOUD Prior Auth - B FIN
Livshin, Michelle On Our Own of Maryland, Inc. FAV 2022-SB323-FAV-OOOMD.pdf FIN
Coble, Annie Johns Hopkins FAV SB323 - Hopkins - Support .pdf FIN
Turner, Nancy MATOD & Serenity Health FAV Oral Testimony
MATOD - SB 323 FAV - Opioid Use Disorder Medicatio
FIN
Ciekot, Ann NCADD-Maryland FAV Oral Testimony
NCADD-MD - SB 323 FAV - OUD PA Prohibition.pdf
FIN
Walters, Vickie MD Association for the Treatment of Opioid Dependence FAV Oral Testimony FIN
Allen, Emily Mental Health Association of Maryland FAV Oral Testimony
SB0323 Opioid Use Disorder Drug Prior Authorizatio
FIN
Farah, Ramsay Phoenix Health Center FAV Oral Testimony FIN
(MD), State of Maryland INFO 4 - SB 323 - FIN - MDH - LOI.docx.pdf FIN
Kasemeyer, Pam FAV SB0323_FAV_MedChi, MDAAP, MACHC_Prior Auth. Drug P FIN
Adams, MD, Joseph Maryland-DC Society of Addiction Medicine FAV Oral Testimony
MDDCSAM FAV Prior Auth SB 323.pdf
FIN
Hays, Kathleen Maryland Rural Health Association INFO MRHA SB323- Maryland Medical Assistance Program-Pr FIN
Testimony, All N/A Merged Testimony as of 2-5-2022 at 627 PM FIN
Senator Augustine, Senator Augustine FAV Oral Testimony HGO
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - SB 323 FAV - OUD PA Prohibition - House HGO
Grollmes, Joshua MATOD FAV MATOD - SB 323 FAV - Opioid Use Disorder Medicatio HGO
Allen, Emily Mental Health Association of Maryland FAV SB0323 Medications to Treat and Opioid Use Disorde HGO
Click to return on the top page